ConductScience.org, home

Trial · NCT00084929

Outcomes13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Advanced Adenomas (>=10mm) as Determined by Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With Advanced Adenomas (>=9mm) Detected by CT Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With Advanced Adenomas (>=8mm) Detected by CT Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With Advanced Adenomas (>=7mm) Detected by CT Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With Advanced Adenomas (>=6mm) Detected by CT Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Participants With Advanced Adenomas (>=5mm) Detected by CT Colonoscopy (Per Patient)within 30 daysParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=10mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=9mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=8mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=7mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=6mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYNumber of Advanced Adenoma or Cancer Lesions (>=5mm) Detected by CT Colonoscopy (Per Lesion)within 30 dayslesionsCOUNT_OF_UNITS
SECONDARYInterobserver Sensitivity Variabilityat baseline
15 readers read the 2531 case and their sensitivity was calculated as well as the variability (95% CI) in Sensitivity within 2 reader groups: High performing (HP) and not high performing (NHP). HP readers had both a sensitivity and specificity of \> 85% for detecting polyps 10 mm and larger, NHP did not.
probability of (test+ given disease+)MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00084929/outcomes